Skip to main content
رجوع
Watch Compare

Retrieve Medical Holdings, Inc.

جودة البيانات: 83%
RMHI
OTC Manufacturing Chemicals
KWD 1.00
KWD 0.00 (0.00%)
القيمة السوقية: 25.67 M
السعر
KWD 1.00
القيمة السوقية
25.67 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—

Quick Summary

النقاط الرئيسية

Negative free cash flow of -55,834.0

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROIC-148.04%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current RatioN/A
Interest Coverage-8.84

التقييم

PE (TTM)
-117.85
أقل من متوسط القطاع (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -117.9 -1.5
P/B — 1.6
ROE % — -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -217,856.0
ROE N/A ROA -184.18%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -55,834.0
ROIC -148.04% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage -8.84 Asset Turnover N/A
Working Capital N/A Tangible Book Value -603,396
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -117.85 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0.22%
Market Cap 25.67 M Enterprise Value 25.67 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 25.63%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019 FY2018
Revenue — — — — —
Net Income -164,969.0 -76,089.0 -15,011.0 -13,993.0 -28,407.0
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -163,302.0 -68,721.0 -5,535.0 -5,684.0 -27,823.0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 32,081.0 10,397.0 9,476.0 8,309.0 5,584.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019 FY2018
Total Assets 130,349.0 261,152.0 408.0 527.0 2,270.0
Total Liabilities 621,503.0 587,337.0 250,504.0 235,612.0 223,362.0
Shareholders' Equity -491,154.0 -326,185.0 -250,096.0 -235,085.0 -221,092.0
Total Debt — — — — —
Cash & Equivalents — — 0.0 0.0 0.0
Current Assets — — 408.0 527.0 2,270.0
Current Liabilities — — 250,504.0 235,612.0 223,362.0